Casdin Partners GP, LLC's Form 4 filing
Absci CorpABSI · filed Jul 28, 2021
- Accession no.
- 0001628280-21-014732
- Filed
- Jul 28, 2021, 4:33 PM ET
- Trade date
- Jul 26, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market purchases total $25.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Casdin Partners GP, LLCCIK 0001534260 | Director |
| Casdin Capital, LLCCIK 0001534261 | Director |
| Casdin Partners Master Fund, L.P.CIK 0001534265 | Director |
| Casdin Private Growth Equity Fund, L.P.CIK 0001823061 | Director |
| Casdin Private Growth Equity Fund GP, LLCCIK 0001864554 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 26, 2021 | Common Stock | CConversionAcquired | +4,209,573 | $0.00F1 | $0 | 4,209,573 | Direct | |
| Jul 26, 2021 | Common Stock | CConversionAcquired | +973,260 | $0.00F3 | $0 | 5,182,833 | Direct | |
| Jul 26, 2021 | Common Stock | PPurchaseAcquired | +1,562,500 | $16.00 | +$25,000,000 | 6,745,333 | Direct | Duplicate filing |
| Jul 26, 2021 | Common Stock | CConversionAcquired | +973,260 | $0.00F3 | $0 | 973,260 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 26, 2021 | Common Stock | CConversionDisposed | −4,209,573 | $0.00 | $0 | 0 | Direct | |
| Jul 26, 2021 | Common Stock | CConversionDisposed | −973,260 | $0.00 | – | 0 | Direct | |
| Jul 26, 2021 | Common Stock | CConversionDisposed | −973,260 | $0.00 | – | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These shares of the Series E Preferred Stock automatically converted on a one-for-3.3031 basis into the number of shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), shown in Column 7 immediately upon closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series E Preferred Stock had no expiration date.
Referenced by the price of 1 transaction in Table I.
- F3
This convertible promissory note ("Convertible Note") had a maturity date of September 16, 2023. The principal and accrued interest under the Convertible Note converted upon the closing of the IPO into shares of Common Stock at a conversion price equal to $13.12 per share without payment of additional consideration.
Referenced by the price of 2 transactions in Table I.
Remarks
Eli Casdin has been deputized to represent the Reporting Persons on the board of directors of the Issuer. By virtue of Mr. Casdin's representation, for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), each of the Reporting Persons may be deemed directors by deputization of the Issuer. Mr. Casdin files separate Section 16 reports disclosing securities of the Issuer that he may be deemed to beneficially own for Section 16 purposes.